Assenagon Asset Management S.A. Axsome Therapeutics, Inc. Transaction History
Assenagon Asset Management S.A.
- $54.1 Billion
- Q4 2024
A detailed history of Assenagon Asset Management S.A. transactions in Axsome Therapeutics, Inc. stock. As of the latest transaction made, Assenagon Asset Management S.A. holds 3,701 shares of AXSM stock, worth $402,853. This represents 0.0% of its overall portfolio holdings.
Number of Shares
3,701
Previous 4,483
17.44%
Holding current value
$402,853
Previous $402,000
22.14%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding AXSM
# of Institutions
329Shares Held
37.8MCall Options Held
912KPut Options Held
855K-
Rtw Investments, LP New York, NY4.19MShares$456 Million6.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA4MShares$435 Million0.01% of portfolio
-
Black Rock Inc. New York, NY3.3MShares$359 Million0.01% of portfolio
-
Fairmount Funds Management LLC Philadelphia, PA2.36MShares$257 Million34.46% of portfolio
-
Bvf Inc San Francisco, CA1.05MShares$114 Million2.99% of portfolio
About Axsome Therapeutics, Inc.
- Ticker AXSM
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 42,878,000
- Market Cap $4.67B
- Description
- Axsome Therapeutics, Inc., a biopharmaceutical company, engages in the development of novel therapies for central nervous system (CNS) disorders in the United States. The company's product pipeline includes AXS-05, a therapeutic for the treatment of major depressive disorder and resistant depression disorders; and that is in the Phase III clinic...